logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

Soldier Health (00314) purchased 49,200 shares for 119,000 Hong Kong dollars on December 24th.

date
14:42 24/12/2025
avatar
GMT Eight
Si Pai Health (00314) announced on December 24, 2025 that it has repurchased 49,200 shares at a total cost of HKD 119,000.
Soldier Health (00314) announced on December 24, 2025 to spend HK$119,000 to repurchase 49,200 shares.
Related Articles
HK Stock
Bank of China (03988) has completed the issuance of 50 billion yuan of subordinate capital bonds.
Goldman Sachs Group, Inc.: Bullish on the aerospace sector's "disruptive" opportunities, Rocket Lab (RKLB.US) sets a new record for government orders, with a target price of $47.
China Stock
Livzon Pharmaceutical Group Inc. (000513.SZ): Application for market approval of Lepikacumab injection received.
Bank of China (03988) has completed the issuance of 50 billion yuan of subordinate capital bonds.
HK Stock
Goldman Sachs Group, Inc.: Bullish on the aerospace sector's "disruptive" opportunities, Rocket Lab (RKLB.US) sets a new record for government orders, with a target price of $47.
Livzon Pharmaceutical Group Inc. (000513.SZ): Application for market approval of Lepikacumab injection received.
China Stock
RECOMMEND
Bank Of America’s Hartnett Warns Market May Be “Overly Optimistic” As Investors Position For A Strong 2026
Bank Of America’s Hartnett Warns Market May Be “Overly Optimistic” As Investors Position For A Strong 2026
icon
23/12/2025
In 2025, More Than 30 Beauty Companies Pursued IPOs, Only Six Succeeded
In 2025, More Than 30 Beauty Companies Pursued IPOs, Only Six Succeeded
icon
23/12/2025
Goldman Sachs 2026 Global Equity Outlook: A Broader Bull Market And Wider AI Beneficiaries
Goldman Sachs 2026 Global Equity Outlook: A Broader Bull Market And Wider AI Beneficiaries
icon
23/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.